📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge. (2017)

First Author: Opriessnig T

Attributed to: Host responses underlying immunity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13567-017-0472-z

PubMed Identifier: 29073936

Publication URI: http://europepmc.org/abstract/MED/29073936

Type: Journal Article/Review

Volume: 48

Parent Publication: Veterinary research

Issue: 1

ISSN: 0928-4249